Axa’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-560
| Closed | -$34K | – | 1068 |
|
2023
Q3 | $34K | Hold |
560
| – | – | ﹤0.01% | 1053 |
|
2023
Q2 | $36.8K | Sell |
560
-665
| -54% | -$43.8K | ﹤0.01% | 1068 |
|
2023
Q1 | $77.9K | Sell |
1,225
-750
| -38% | -$47.7K | ﹤0.01% | 1084 |
|
2022
Q4 | $273K | Buy |
+1,975
| New | +$273K | ﹤0.01% | 1060 |
|
2021
Q1 | – | Sell |
-16,024
| Closed | -$8.98M | – | 1219 |
|
2020
Q4 | $8.98M | Buy |
16,024
+3,283
| +26% | +$1.84M | 0.03% | 549 |
|
2020
Q3 | $8.9M | Buy |
12,741
+2,423
| +23% | +$1.69M | 0.03% | 492 |
|
2020
Q2 | $8.16M | Buy |
+10,318
| New | +$8.16M | 0.03% | 484 |
|
2018
Q3 | – | Sell |
-1,598
| Closed | -$3.25M | – | 1334 |
|
2018
Q2 | $3.25M | Sell |
1,598
-371
| -19% | -$754K | 0.01% | 745 |
|
2018
Q1 | $4.35M | Buy |
1,969
+47
| +2% | +$104K | 0.02% | 690 |
|
2017
Q4 | $4.44M | Buy |
1,922
+1,073
| +126% | +$2.48M | 0.02% | 686 |
|
2017
Q3 | $1.51M | Sell |
849
-3,586
| -81% | -$6.38M | 0.01% | 866 |
|
2017
Q2 | $6.04M | Sell |
4,435
-5,127
| -54% | -$6.98M | 0.03% | 561 |
|
2017
Q1 | $11.3M | Sell |
9,562
-562
| -6% | -$662K | 0.05% | 386 |
|
2016
Q4 | $8.09M | Sell |
10,124
-2,510
| -20% | -$2.01M | 0.04% | 462 |
|
2016
Q3 | $11.1M | Buy |
12,634
+7
| +0.1% | +$6.15K | 0.05% | 370 |
|
2016
Q2 | $7.08M | Buy |
12,627
+1,136
| +10% | +$637K | 0.03% | 487 |
|
2016
Q1 | $6.33M | Buy |
11,491
+1,857
| +19% | +$1.02M | 0.03% | 495 |
|
2015
Q4 | $8.02M | Sell |
9,634
-690
| -7% | -$574K | 0.04% | 444 |
|
2015
Q3 | $11.4M | Buy |
10,324
+3,888
| +60% | +$4.31M | 0.05% | 351 |
|
2015
Q2 | $14M | Hold |
6,436
| – | – | 0.06% | 323 |
|
2015
Q1 | $10.1M | Buy |
6,436
+1,114
| +21% | +$1.74M | 0.04% | 407 |
|
2014
Q4 | $6.32M | Buy |
+5,322
| New | +$6.32M | 0.03% | 492 |
|